Home
>
National Drug Code (NDC)
>
IMOGAM RABIES-HT
IMOGAM RABIES-HT - 49281-190-20 - (HUMAN RABIES VIRUS IMMUNE GLOBULIN)
Drug Information of IMOGAM RABIES-HT
| Product NDC: | 49281-190 |
| Proprietary Name: | IMOGAM RABIES-HT |
| Non Proprietary Name: | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Active Ingredient(s): | 150 [iU]/mL & nbsp; HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of IMOGAM RABIES-HT
| Product NDC: | 49281-190 |
| Labeler Name: | Sanofi Pasteur Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103932 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19840427 |
Package Information of IMOGAM RABIES-HT
| Package NDC: | 49281-190-20 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (49281-190-20) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of IMOGAM RABIES-HT
| NDC Code | 49281-190-20 |
| Proprietary Name | IMOGAM RABIES-HT |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (49281-190-20) > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 49281-190 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19840427 |
| Marketing Category Name | BLA |
| Labeler Name | Sanofi Pasteur Inc. |
| Substance Name | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Strength Number | 150 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes |
